Patent · US Active

Macrocyclic inhibitors of hepatitis C virus

US8148399B2 · kind B2 · utility

20Cited by
8References
15Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJul 28, 2006
Grant dateApr 3, 2012
Priority date
Expiry dateSep 5, 2029

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Inhibitors of HCV replication of formula (I)and the N-oxides, salts, and stereoisomers, wherein each dashed line represents an optional double bond;

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.